IRD insider filings

Opus Genetics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-05. Screen IRD transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 9 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Foundation Fighting Blindness Retinal Degeneration Fund — Director & Foundation Fighting Blindness, Inc. — Director1—1 leg · 556,000 sh · $2,755,981—
Gagnon Robert E. — Chief Financial Officer2—2 legs · 42,000 sh · $176,862—
Magrath George — Chief Executive Officer, Director3—2 legs · 37,849 sh · $144,5673
YERXA BENJAMIN R — President, Director1—2 legs · 33,189 sh · $117,365—
SCHACHLE JOSEPH K — Chief Operating Officer1—1 leg · 4,767 sh · $16,994—
Gallagher Cam — Director1——2

Recent insider filings — Opus Genetics, Inc.

FiledFormInsiderReported transactionsSource
2026-11-054Magrath George — Chief Executive Officer, DirectorSale (S): 28,258 @ $3.90EDGAR
2026-10-274SCHACHLE JOSEPH K — Chief Operating OfficerSale (S): 4,767 @ $3.56EDGAR
2026-10-274YERXA BENJAMIN R — President, DirectorSale (S): 7,669 @ $3.55 · Sale (S): 25,520 @ $3.53EDGAR
2026-10-274Gagnon Robert E. — Chief Financial OfficerSale (S): 14,000 @ $3.55EDGAR
2026-10-274Magrath George — Chief Executive Officer, DirectorSale (S): 9,591 @ $3.58EDGAR
2026-10-024Foundation Fighting Blindness Retinal Degeneration Fund — Director
Foundation Fighting Blindness, Inc. — Director
Sale (S): 556,000 @ $4.96EDGAR
2026-09-114Magrath George — Chief Executive Officer, DirectorOption exercise (M): 392,157 @ $1.15 · Tax withholding (F): 75,541 @ $5.97 · Option exercise (M): 392,157 (derivative) @ $0EDGAR
2026-09-084Gagnon Robert E. — Chief Financial OfficerSale (S): 28,000 @ $4.54EDGAR
2026-09-084Gallagher Cam — DirectorOption exercise (M): 784,314 @ $1.15 · Option exercise (M): 784,314 (derivative) @ $0EDGAR
2026-07-274Gagnon Robert E. — Chief Financial OfficerSale (S): 7,783 @ $2.95EDGAR
2026-07-274Magrath George — Chief Executive Officer, DirectorSale (S): 9,475 @ $2.95EDGAR
2026-07-274SCHACHLE JOSEPH K — Chief Operating OfficerSale (S): 4,644 @ $2.94EDGAR
2026-07-274YERXA BENJAMIN R — President, DirectorSale (S): 7,429 @ $2.97EDGAR
2026-05-204Foundation Fighting Blindness Retinal Degeneration Fund — Director
Foundation Fighting Blindness, Inc. — Director
Sale (S): 1,700,000 @ $4.35EDGAR
2026-04-274Zaremba Rabourn Amy — Head of Fin. Quality AssuranceSale (S): 1,641 @ $5.20EDGAR
2026-04-274Magrath George — Chief Executive Officer, DirectorSale (S): 9,511 @ $5.22EDGAR
2026-04-274Jayagopal Ashwath — Chief Scientific & Dev. Ofc.Sale (S): 7,542 @ $5.19EDGAR
2026-04-274Gagnon Robert E. — Chief Financial OfficerSale (S): 7,842 @ $5.18EDGAR
2026-04-274SCHACHLE JOSEPH K — Chief Operating OfficerSale (S): 4,697 @ $5.22EDGAR
2026-04-274YERXA BENJAMIN R — President, DirectorSale (S): 7,470 @ $5.24EDGAR
2026-04-224Rodgers Richard J — DirectorGrant/award (A): 24,367 @ $0EDGAR
2026-04-224MANUSO JAMES S J — DirectorGrant/award (A): 24,367 @ $0EDGAR
2026-04-224Graves Adrienne L — DirectorGrant/award (A): 24,367 @ $0EDGAR
2026-04-224Gallagher Cam — DirectorGrant/award (A): 24,367 @ $0EDGAR
2026-04-224Benton Susan — DirectorGrant/award (A): 24,367 @ $0EDGAR
2026-04-224Bennett Jean — DirectorGrant/award (A): 24,367 @ $0EDGAR
2026-04-224Ainsworth Sean — DirectorGrant/award (A): 24,367 @ $0EDGAR
2026-03-184Zaremba Rabourn Amy — Head of Fin. Quality AssuranceSale (S): 2,816 @ $5.25EDGAR
2026-03-184Magrath George — Chief Executive Officer, DirectorSale (S): 24,438 @ $5.21EDGAR
2026-03-184Jayagopal Ashwath — Chief Scientific & Dev. Ofc.Sale (S): 3,719 @ $5.12EDGAR
2026-03-184SCHACHLE JOSEPH K — Chief Operating OfficerSale (S): 3,719 @ $5.25EDGAR
2026-02-174Jayagopal Ashwath — Chief Scientific & Dev. Ofc.Tax withholding (F): 5,313 @ $3.39EDGAR
2026-01-264Zaremba Rabourn Amy — Head of Fin. Quality AssuranceGrant/award (A): 86,500 @ $0EDGAR
2026-01-264Magrath George — Chief Executive Officer, DirectorGrant/award (A): 483,639 @ $0EDGAR
2026-01-264Jayagopal Ashwath — Chief Scientific & Dev. Ofc.Grant/award (A): 400,000 @ $0EDGAR
2026-01-264Gagnon Robert E. — Chief Financial OfficerGrant/award (A): 400,000 @ $0EDGAR
2026-01-264SCHACHLE JOSEPH K — Chief Operating OfficerGrant/award (A): 250,000 @ $0EDGAR
2026-01-264YERXA BENJAMIN R — President, DirectorGrant/award (A): 400,000 @ $0EDGAR
2026-01-214Zaremba Rabourn Amy — Head of Fin. Quality AssuranceTax withholding (F): 3,390 @ $2.10EDGAR
2026-01-134Zaremba Rabourn Amy — Head of Fin. Quality AssuranceTax withholding (F): 3,950 @ $1.93EDGAR
2026-01-084Gallagher Cam — DirectorGrant/award (A): 67,000 @ $0EDGAR
2026-01-054MANUSO JAMES S J — DirectorGrant/award (A): 31,188EDGAR
2026-01-054Graves Adrienne L — DirectorGrant/award (A): 23,643EDGAR
2026-01-054Bennett Jean — DirectorGrant/award (A): 21,127EDGAR
2026-01-054Ainsworth Sean — DirectorGrant/award (A): 42,507EDGAR
2025-12-314Gallagher Cam — DirectorPurchase (P): 81,000 @ $1.98 · Purchase (P): 83,000 @ $1.97 · Grant/award (A): 33,000 @ $0EDGAR
2025-12-114Foundation Fighting Blindness Retinal Degeneration Fund — Director
Foundation Fighting Blindness, Inc. — Director
Sale (S): 4,000,000 @ $2.15EDGAR
2025-11-054/AMagrath George — Chief Executive Officer, DirectorTax withholding (F): 30,350 @ $2.30EDGAR
2025-11-044Magrath George — Chief Executive Officer, DirectorTax withholding (F): 30,350 @ $2.30EDGAR
2025-10-244YERXA BENJAMIN R — President, DirectorTax withholding (F): 23,795 @ $1.95EDGAR

Recent 8-K events — Opus Genetics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-218-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-158-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-118-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-098-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-168-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-168-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-248-K2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a RegistrantEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=IRD returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs